Strategy infographic image 2

Last updated on 24 Nov 2023

In the last 18 months we have

Made taking part easier

We’ve published more support and guidance for clinical trials outside hospitals, so patients have more choice about where they take part in research

Identified what people want research to look like

Our principles and hallmarks of research that put people first are changing practice so more people will feel confident to take part

Stood together with 20 organisations to increase public involvement in research so that it is designed and talked about in ways that people can trust

Given applicants more control

Over 280 applications have used our fast-track research ethics review, done in 20 days

Helped make it 100 days faster to set up studies

The enhanced National Contract Value Review (NCVR) means it’s quicker and easier to set up commercial clinical trials

Supported digital innovators

More than 1800 researchers and innovators have used the new AI and Digital Regulations Service which we were key partners in creating

In the next 18 months we will

Save time and money
Create a UK-wide approval service for your research

Transform our digital services
We’re updating the online systems you use to manage your research

Increase registration of research
Two thirds of people (65%) would feel more confident in health and social care research findings if the project was added to a public register before it started

Support more diversity in research
Diverse trials provide more robust clinical data, which is good for research and patients. We will publish guidance to support involving more people in research that is relevant to them

Make sure clinical trials happen in a way that matters to people
We will inform updates to the law governing clinical trials so people can trust them

There is still work to do, but I’m confident that the UK can regain our world-leading position in clinical research. Good quality research is vital to the NHS and the HRA plays a crucial role in accelerating research and building trust in the system, which encourages more people to take part in clinical trials and supports more successful research.

Lord O’Shaughnessy
Back to our strategy